In recent past, minimally invasive surgery has become standard for treating various types of cancers because of the way it is designed to reduce the physical trauma associated with traditional open surgeries, particularly in procedures like prostatectomy, colectomies, and hysterectomies. By utilizing smaller incisions and advanced imaging technologies such as high-definition cameras and 3D visualization, MIS has improved surgical outcomes and precision, allowing for faster recovery times, reduced blood loss, and shorter hospital stays.
For example, robotic-assisted techniques used in prostate cancer surgery or gynecologic oncological procedures enable precise dissection and tumor removal while preserving surrounding tissue and organs, reducing the risk of nerve damage or organ injury. Similarly, in colorectal cancer surgery, robotic-assisted laparoscopic techniques allow surgeons to perform complex resections with greater accuracy, minimizing the risk of bowel obstruction and anastomotic leaks, while preserving critical vascular structures and improving the overall recovery process. Recent innovations have led to more refined surgical techniques, improved robotic instrumentation, and better training for surgical teams, resulting in reduced rates of postoperative pain, fewer infections, and quicker rehabilitation times.
However, MIS also faces challenges. Knowing when it is the best treatment option is key to achieving optimal outcomes. In some cases, the limitations of MIS, such as difficulty visualizing deeper or hidden tumors, may impact outcomes.
With this in mind, BMC Cancer is opening this Collection on "Minimally invasive cancer surgery." We welcome submissions on the following:
- Advances in robotic-assisted surgical techniques
- Patient outcomes in minimally invasive cancer surgery
- Comparative effectiveness of traditional vs. minimally invasive approaches
- Innovations in surgical instrumentation and technology
- Identification of optimal scenarios for minimally invasive surgery, considering factors like cancer type, stage, and patient health
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Image credit: © Nekrasov / Stock.adobe.com